Trials / Completed
CompletedNCT06458556
Transvaginal Radiofrequency Ablation for Overactive Bladder
Transvaginal Radiofrequency Ablation With Morpheus Device for Treatment of Overactive Bladder.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- InMode MD Ltd. · Industry
- Sex
- Female
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
To assess the effectiveness of transvaginal radiofrequency oblation by the Morpheus device at varying depths of penetration for improving urge predominate and urinary incontinence symptoms in women with overactive bladder .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Treatment with Morpheus | Radiofrequency device treatment |
Timeline
- Start date
- 2023-06-19
- Primary completion
- 2024-05-30
- Completion
- 2024-05-30
- First posted
- 2024-06-13
- Last updated
- 2024-06-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06458556. Inclusion in this directory is not an endorsement.